Federal Circuit Agrees Claims Of Kidney Drug Patents Not Infringed
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on May 21 affirmed a Delaware federal judge’s finding that a biopharmaceutical company’s patents related to a medication to treat...To view the full article, register now.
Already a subscriber? Click here to view full article